Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.
2.

Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception.

Rossi GC, Leventhal L, Pan YX, Cole J, Su W, Bodnar RJ, Pasternak GW.

J Pharmacol Exp Ther. 1997 Apr;281(1):109-14.

4.

Morphine-6beta-glucuronide-induced hyperphagia: characterization of opioid action by selective antagonists and antisense mapping in rats.

Leventhal L, Silva RM, Rossi GC, Pasternak GW, Bodnar RJ.

J Pharmacol Exp Ther. 1998 Nov;287(2):538-44.

5.

Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions.

Pan YX, Xu J, Xu M, Rossi GC, Matulonis JE, Pasternak GW.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4917-22. doi: 10.1073/pnas.0811586106. Epub 2009 Mar 9.

6.

Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.

Doyle GA, Sheng XR, Lin SS, Press DM, Grice DE, Buono RJ, Ferraro TN, Berrettini WH.

Gene. 2007 Jun 15;395(1-2):98-107. Epub 2007 Feb 20.

7.

Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.

Rossi GC, Brown GP, Leventhal L, Yang K, Pasternak GW.

Neurosci Lett. 1996 Sep 20;216(1):1-4.

PMID:
8892377
8.

Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.

Schuller AG, King MA, Zhang J, Bolan E, Pan YX, Morgan DJ, Chang A, Czick ME, Unterwald EM, Pasternak GW, Pintar JE.

Nat Neurosci. 1999 Feb;2(2):151-6.

PMID:
10195199
9.

Antisense oligodeoxynucleotide targeting distinct exons of the cloned mu-opioid receptor distinguish between endomorphin-1 and morphine supraspinal antinociception in mice.

Sánchez-Blázquez P, DeAntoio I, Rodríguez-Díaz M, Garzón J.

Antisense Nucleic Acid Drug Dev. 1999 Jun;9(3):253-60.

PMID:
10435750
10.

The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence.

Klein G, Rossi GC, Waxman AR, Arout C, Juni A, Inturrisi CE, Kest B.

Neurosci Lett. 2009 Jul 3;457(3):115-9. doi: 10.1016/j.neulet.2009.04.012. Epub 2009 Apr 9.

PMID:
19429175
11.

14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile.

King MA, Su W, Nielan CL, Chang AH, Schütz J, Schmidhammer H, Pasternak GW.

Eur J Pharmacol. 2003 Jan 17;459(2-3):203-9.

PMID:
12524147
12.

Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor.

Rossi G, Pan YX, Cheng J, Pasternak GW.

Life Sci. 1994;54(21):PL375-9.

PMID:
8196473
13.

Antisense mapping DOR-1 in mice: further support for delta receptor subtypes.

Rossi GC, Su W, Leventhal L, Su H, Pasternak GW.

Brain Res. 1997 Apr 4;753(1):176-9.

PMID:
9125445
14.

Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats.

Silva RM, Rossi GC, Mathis JP, Standifer KM, Pasternak GW, Bodnar RJ.

Brain Res. 2000 Sep 8;876(1-2):62-75.

PMID:
10973594
15.

Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants.

Abbadie C, Rossi GC, Orciuolo A, Zadina JE, Pasternak GW.

Eur J Neurosci. 2002 Sep;16(6):1075-82.

PMID:
12383236
16.

Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.

Pan YX, Xu J, Bolan E, Abbadie C, Chang A, Zuckerman A, Rossi G, Pasternak GW.

Mol Pharmacol. 1999 Aug;56(2):396-403.

17.

Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.

Doyle GA, Rebecca Sheng X, Lin SS, Press DM, Grice DE, Buono RJ, Ferraro TN, Berrettini WH.

Gene. 2007 Feb 15;388(1-2):135-47. Epub 2006 Nov 1.

PMID:
17156941
18.

Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1.

Xu J, Xu M, Rossi GC, Pasternak GW, Pan YX.

Mol Pain. 2011 Jan 21;7:9. doi: 10.1186/1744-8069-7-9.

19.

Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine.

Gilbert AK, Hosztafi S, Mahurter L, Pasternak GW.

Eur J Pharmacol. 2004 May 25;492(2-3):123-30.

PMID:
15178355
20.

Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO.

Leventhal L, Stevens LB, Rossi GC, Pasternak GW, Bodnar RJ.

J Pharmacol Exp Ther. 1997 Sep;282(3):1402-7.

Supplemental Content

Support Center